CJC-1295 DAC

It’s a tetra substituted peptide that is made up of 30 amino acids. CJC-1295 has been revealed through scientific studies to be bio-conjugating to the protein blood albumin (serum albumin), which typically provides an advanced homeostasis level in the animals that are being tested. Using CJC-1295 with DAC prevents DPP-IV production from happening in scientific studies that involved animal test subjects.

That leads to the GHRH1-29 undergoing an extended half-life, one that can last more than one week. With the increased GHRH1-29 stabilisation, GHs are capable of functioning at greater levels plus test subjects are then capable of experiencing an increased stability level in the growth hormones. Generally, CJC-1295 with DAC is known to be preferred because it is a more powerful growth hormone-releasing hormone component in the protocol of a peptide.

Throughout scientific studies that have carried out, it has been understood that CJC-1295 with DAC presence allows for a less elevated processes test subjects occurrence. This includes Body Fat Reduction, Increased Bone Density and Muscular Tissue Growth.